 |
The Brain Tumor Society (BTS) was a charitable organization based in Watertown, Massachusetts. It was founded in 1989.
In 2008, the Brain Tumor Society merged with the National Brain Tumor Foundation to form the National Brain Tumor Society. [1]
The mission of the BTS was strategically designed from the inception of the organization to have the greatest impact on all of those affected by a brain tumor, including caregivers and healthcare professionals. Their short-term goals were focused on improving the quality of life for patients, survivors and their families by providing psychosocial support and educational materials, such as their newsletter, Heads Up, and their comprehensive Resource Guide, Color Me Hope. For the long-term, they hoped to accelerate the discovery of new treatments and cures for this debilitating and often fatal disease by raising money to fund scientific research. Thus began their three-pronged approach of Research, Education and Support.
Torsten Nils Wiesel is a Swedish neurophysiologist. Together with David H. Hubel, he received the 1981 Nobel Prize in Physiology or Medicine, for their discoveries concerning information processing in the visual system; the prize was shared with Roger W. Sperry for his independent research on the cerebral hemispheres.
Nancy Coover Andreasen is an American neuroscientist and neuropsychiatrist. She currently holds the Andrew H. Woods Chair of Psychiatry at the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa.
The Orthopaedic Research Society (ORS) is a professional, scientific, and medical organization focused on orthopaedic research. The stated mission of the ORS is to advance orthopaedic research through education, collaboration, communication, and advocacy. The ORS aims to raise resources for orthopaedic research and increase the awareness of the impact of such research on patients and the public.
Philip E. Stieg is an American academic physician and neurosurgeon. He has been the Neurosurgeon-in-Chief of NewYork-Presbyterian/Weill Cornell Medical Center since 2000.
Fight for Sight is a nonprofit organization in the United States which funds medical research in vision and ophthalmology. It was formed in 1946 as the National Council to Combat Blindness (NCCB), the first non-profit in the United States to fund vision research; 2011 marked its 65th anniversary.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and Co-Director, Johns Hopkins Clinical Research Network.
The National Brain Tumor Society (NBTS) is the largest non-profit organization dedicated to the brain tumor community in the United States. It was formed in 2008 by the merger of the National Brain Tumor Foundation and the Brain Tumor Society. Both organizations had been formed in the 1980s by parents and other individuals who wanted to increase both research funding and access to resources specific to brain tumors.
Barrow Neurological Institute is the world's largest neurological disease treatment and research institution, and is consistently ranked as one of the best neurosurgical training centers in the United States. Founded in 1962, the main campus is located at 350 W. Thomas Road, Phoenix, Arizona.
Professor Minesh P Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
Aaron A. Cohen-Gadol is a professor of neurological surgery in the department of neurosurgery at Indiana University School of Medicine and a neurosurgeon at Indiana University Health specializing in surgical treatment of brain tumors and aneurysms. He performs removal of complex brain tumors via endoscopic techniques, which use the nasal pathways instead of opening the skull.
The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.
The Marfan Foundation is a non-profit organization in the United States established to raise awareness and promote research on treatment of Marfan syndrome and related disorders. The Foundation provides information about Marfan syndrome and funds research for the purposes of saving lives and improving the quality of life for people affected by the condition which is a genetic connective tissue disorder. The Foundation also lobbies Congress to fund Marfan syndrome research and engages in its own fundraising activities.
Ravi V. Bellamkonda is a biomedical engineer and provost of Emory University.
Luis F. Parada is a Colombian developmental biologist and neuroscientist who currently serves as Director of the Brain Tumor Center, Albert C. Foster Chair and American Cancer Society Research Professor at Memorial Sloan Kettering Cancer Center in New York City, New York.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Duane A. Mitchell, M.D., Ph.D. is an American physician-scientist and university professor. He is currently employed at the University of Florida College of Medicine, in Gainesville, Florida as the Assistant Vice President for Research, Associate Dean for Translational Science and Clinical Research, and Director of the University of Florida (UF) Clinical and Translational Science Institute. He is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery. and Co-Director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy. Dr. Mitchell is also the Founder, President, and Chairman of iOncologi, Inc., a biotechnology company in Gainesville, FL specializing in immuno-oncology.
Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. She has published over 170 research articles and a textbook, Brain Tumor Immunotherapy. She served as editor-in-chief of the Journal of Neuro-Oncology from 2007 to 2017.
National Cancer Center, founded in 1953, is a (501)(c)(3) not-for-profit organization in the United States that funds young cancer researchers who are working to discover how the body's immune system sees and responds to cancer when it initially develops and why certain cancer cells are resistant to different treatments. The organization also provides educational information to the public on the prevention, diagnosis and treatment of cancer.
David Hillel Gutmann is an American neurologist. He teaches at Washington University in St. Louis, where he is the Donald O. Schnuck Family Professor, Vice Chair for Research Affairs for the Department of Neurology, and director of the Neurofibromatosis Center at He is an international expert in Neurofibromatosis, pioneering the use of preclinical models to understand brain tumors and neurodevelopmental delays in children with NF1.
| General | |
|---|---|
| National libraries | |
 | This article about a philanthropic or charitable organization in the United States is a stub. You can help Wikipedia by expanding it. |
